Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Metabolism Drugs
The 2025-2030 World Outlook for Metabolism Drugs This study covers the world outlook for metabolism drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Anti-Hypertensive Diuretic Drugs
The 2025-2030 World Outlook for Anti-Hypertensive Diuretic Drugs This study covers the world outlook for anti-hypertensive diuretic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitor Drugs
The 2025-2030 World Outlook for Tumor Necrosis Factor Inhibitor Drugs This study covers the world outlook for tumor necrosis factor inhibitor drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Cushing's Syndrome Diagnostics and Treatments
The 2025-2030 World Outlook for Cushing's Syndrome Diagnostics and Treatments This study covers the world outlook for Cushing's syndrome diagnostics and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Cell-Based Brain Tumor Therapeutics
The 2025-2030 World Outlook for Cell-Based Brain Tumor Therapeutics This study covers the world outlook for cell-based brain tumor therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics This study covers the world outlook for cystic fibrosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Rheumatology Therapeutics
The 2025-2030 World Outlook for Rheumatology Therapeutics This study covers the world outlook for rheumatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Orphan Diseases Therapeutics in Oncology
The 2025-2030 World Outlook for Orphan Diseases Therapeutics in Oncology This study covers the world outlook for orphan diseases therapeutics in oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Von Willebrand Disease Treatments
The 2025-2030 World Outlook for Von Willebrand Disease Treatments This study covers the world outlook for Von Willebrand disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Pruritus Therapeutics
The 2025-2030 World Outlook for Pruritus Therapeutics This study covers the world outlook for pruritus therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Pruritus Corticosteroid Therapeutics
The 2025-2030 World Outlook for Pruritus Corticosteroid Therapeutics This study covers the world outlook for pruritus corticosteroid therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Artificial Intelligence in Medicines
The 2025-2030 World Outlook for Artificial Intelligence in Medicines This study covers the world outlook for artificial intelligence in medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Pain Management Therapeutics
The 2025-2030 World Outlook for Pain Management Therapeutics This study covers the world outlook for pain management therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Treatments
The 2025-2030 World Outlook for Osteoporosis Treatments This study covers the world outlook for osteoporosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disease Therapeutics
The 2025-2030 World Outlook for Autoimmune Disease Therapeutics This study covers the world outlook for autoimmune disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Migraine Treatments
The 2025-2030 World Outlook for Migraine Treatments This study covers the world outlook for migraine treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Vitiligo Treatments
The 2025-2030 World Outlook for Vitiligo Treatments This study covers the world outlook for vitiligo treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Microbiome Therapeutics for Type 2 Diabetes
The 2025-2030 World Outlook for Microbiome Therapeutics for Type 2 Diabetes This study covers the world outlook for microbiome therapeutics for type 2 diabetes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Proliferative Diabetic Retinopathy Treatments
The 2025-2030 World Outlook for Proliferative Diabetic Retinopathy Treatments This study covers the world outlook for proliferative diabetic retinopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Ulcerative Colitis Therapeutics
The 2025-2030 World Outlook for Ulcerative Colitis Therapeutics This study covers the world outlook for ulcerative colitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Therapeutics
The 2025-2030 World Outlook for Anti-Inflammatory Therapeutics This study covers the world outlook for anti-inflammatory therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Glaucoma Therapeutics
The 2025-2030 World Outlook for Glaucoma Therapeutics This study covers the world outlook for glaucoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics This study covers the world outlook for transitional cell bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Macrolide Drugs
The 2025-2030 World Outlook for Macrolide Drugs This study covers the world outlook for macrolide drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Huntington's Disease Therapeutics
The 2025-2030 World Outlook for Huntington's Disease Therapeutics This study covers the world outlook for Huntington's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
Research Assistance
